TGFB1 and cancer: However, emerging evidence suggests that the cancer cells themselves might also produce ECM components (Ozdemir et al., 2014), and acquired features of cancer cells, such as the loss of TGFβ signaling, specifically result in increased ECM production (Laklai et al., 2016).